Showing 20 of 81 recruiting trials for “squamous-cell-carcinoma-of-head-and-neck”
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
👨⚕️ Samantha Hedrick, PhD, DABR, Thompson Proton Center, Director of Medical Physics📍 1 site📅 Started Dec 2023View details ↗
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
👨⚕️ Sara Ronchi, MD, CNAO National Center of Oncological Hadrontherapy📍 1 site📅 Started Nov 2023View details ↗
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)
RecruitingNCT05328024 ↗
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
👨⚕️ Luana Guimaraes De Sousa, MD PhD, M.D. Anderson Cancer Center📍 1 site📅 Started Jun 2023View details ↗
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy
👨⚕️ Junlin Yi, Doctor, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC📍 1 site📅 Started Jan 2023View details ↗
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
👨⚕️ Huang Xiaoming, M.D., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University📍 1 site📅 Started Sep 2022View details ↗
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
👨⚕️ Zeinab Abou Yehia, MD, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Sep 2022View details ↗
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
👨⚕️ Minghua Ge, PhD, Zhejiang Provincial People's Hospital📍 7 sites📅 Started Sep 2022View details ↗
RecruitingNCT05539638 ↗
The Role of Circulating Tumour DNA in Head and Neck Cancer
Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
RecruitingNCT05483374 ↗
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
👨⚕️ Annalisa Trama, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano📍 12 sites📅 Started May 2022View details ↗
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →